For patients with heart failure with preserved ejection fraction (HFpEF), endovascular treatment (EVT) improves left ...
For patients with heart failure with preserved ejection fraction (HFpEF), endovascular treatment (EVT) improves left ...
The main goals of the pharmacological treatment of Heart failure with reduced ejection fraction (HFrEF) are the reduction of mortality and the prevention of hospitalizations. However, other outcomes ...
Potassium levels that are too high or too low can exacerbate heart failure. Most of the potassium that you need will be consumed in your diet. Foods high in potassium help manage your blood pressure ...
LONDON — The benefit of mineralocorticoid receptor antagonists (MRAs) for the treatment of patients with heart failure and mildly reduced or preserved ejection fraction has finally been ...
The medication, finerenone, could be an effective therapy in people with heart failure who have mildly reduced or preserved ejection fraction, suggests the study, published Sunday in the New Engla ...
Data regarding the efficacy and safety of the nonsteroidal mineralocorticoid receptor antagonist finerenone in patients with heart failure and mildly reduced or preserved ejection fraction are needed.
LONDON, England—Use of the nonsteroidal mineralocorticoid receptor antagonist (MRA) finerenone cuts the risk of worsening HF events and cardiovascular mortality in patients who have heart failure with ...
Finerenone in Heart Failure With Mildly Reduced or Preserved Ejection Fraction. N Engl J Med 2024;Sep 1:[Epub ahead of print]. Presented by Dr. Scott Solomon at the European Society of Cardiology ...
we had nothing coming in from the set and everything has been guarded with no leaks but finally one image of the duo has been dropped by Bhatt herself as a collab post with Sharvari and in a very ...
We conducted a randomized, controlled trial involving patients with heart failure and moderate to severe functional mitral regurgitation from 30 sites in nine countries. The patients were assigned ...